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without limb ischemia
Age
(years)
Male
Gender BSA (m2) BMI
Cannula
Size (Fr)
Mortality
(%)
Limb ischemia 36  18 7/7 2.09  0.29 29.5  10.0 16.9  1.1 4/7 (57)
No limb
ischemia
58  14 20/26 2.13  0.27 30.8  5.4 18.0  1.7 23/26 (88)
Prophylactic-Y 44  16 7/10 2.06  0.23 29.4  9.0 17.7  1.8 7/10 (70)
P-value* 0.001 0.30 0.57 0.65 0.09 0.09
BMI, Body mass index; BSA, body surface area.
*Between “limb ischemia” and “no limb ischemia” groups.
Does the Addition of Routine IVC/Iliac Vein and Infrapopliteal
Duplex Scan Confer any Benefit?
Alhabouni S, Hingorani A, Ascher E, et al
Objectives: The routine evaluation for lower extremity deep vein
thromboses (DVT) usually involves the femoral and popliteal veins with no
regard to the more proximal (Iliac and inferior vena cava [IVC]) veins or the
more distal (infra-popliteal) veins. In this study, we attempted to evaluate
the benefits of routine scanning of these segments.
Methods: We reviewed 1624 consecutive lower extremity venous
duplex studies performed for 1513 of our in-house patients between January
2008 and July 2008. All studies included routine evaluation of the IVC/iliac
and infra-popliteal vein segments. All studies were also evaluated for any
evidence of pulmonary embolism (PE).
Results: The IVC/iliac vein segments were completely evaluated in
1270 duplex studies with evidence of IVC/iliac vein DVTs in 37 (2.9%). In
354 studies, the evaluation was incomplete due to improper visualization of
the IVC mostly due to bowel gas. Despite that, evidence of iliac vein DVT
was noted in 18 (5.1%) of these studies. In total, the addition of routine iliac
vein/IVC duplex scan resulted in the detection of 55 (3.38%) DVTs with
evidence of PE in five (incidence of 9.1%). In five of those 55 duplex studies,
the IVC/iliac vein DVT was the only DVT detected, with evidence of PE in
one (incidence of 20%). The rest of the study population had evidence of
DVT in 244 studies (15.55%) with evidence of PE in 32 (incidence of
13.1%) of them (P  .59). Infra-popliteal segment: 145 infra-popliteal
DVTs were detected, of which 50 (34.5%) were isolated to the infra-
popliteal segments with evidence of PE in three (incidence of 6%). The rest
of the study population showed evidence of DVT in 98 with evidence of PE
in 14 (incidence of 14.3%) (P  .135).
Conclusions: Although routine scanning of the IVC/Iliac veins re-
sulted in detection rate of 3.38%, the detection of an isolated DVT in those
veins was very low (0.3%). However, isolated DVT of the iliac veins had a PE
rate of 20%. As for the routine scanning for infra-popliteal DVTs, 50
additional DVTs were detected with a PE rate of 6%, with no statistical
difference from the rate of PE from more proximal segments (P  .135).
Hence infra-popliteal DVTs should be regarded as risky as more proximal
DVTs and should therefore be treated similarly.
Mechanical-Chemical Endovenous Ablation: A New Tumescentless
Technique
Elias S
Objectives: The minimally invasive management of vein disease contin-
ues to evolve. Endothermal methods to ablate the great and small saphenous
veins involve the use of tumescent anesthesia for analgesia and compressionwith
possible adjunctive intravenous sedation. Foam sclerotherapy of the great and
small saphenous veins has been attempted with mixed results. A new en-
dovenous device that does not require tumescent anesthesia or intravenous
sedation, ClariVein (Vascular Insights LLC, Conn), was evaluated. The Clar-
iVein catheter utilizes endovenous mechanical vein wall destruction with a
rotating wire and the simultaneous infusion of a liquid sclerosant (Sotradecol)
to enhance venous ablation. This endovenous mechanical treatment is unique.
This Institutional Review Board-sanctioned study evaluated the safety and
efficacy of this technique.
Methods: The ClariVein device was utilized in 30 patients with great
saphenous vein incompetence. All procedures were performed in office with
only local anesthesia at the access site. No tumescent anesthesia or intrave-
nous sedation was employed. Ultrasound guidance similar to other en-
dovenous procedures was used. Post treatment care was similar to en-
dovenous thermal ablative procedures.
Results: Total procedure time was less than 15 minutes. Access was at
the lowest level of incompetence but no lower than below the knee. Results
at one week, one month, and three months will be presented including
occlusion rates greater than 90%. Complication rates and symptom resolu-
tion will be discussed.Conclusions: The unique endomechanical ablative aspect of the Clar-
iVein coupled with a safe FDA approved liquid sclerosant represents a furthersimplification and advancement in the treatment of venous disease. This is
accomplished without the tumescent anesthesia currently required for endo-
thermal methods and an early success rate comparable to these methods.
Endovenous Ablation plus Microphlebectomy/Sclerotherapy for the
Treatment of Varicose Veins: A Single or Two-Stage Procedure?
Schanzer H
Objectives: Endovenous ablation (EVA) of the saphenous vein has
almost completely replaced surgical stripping for the treatment of saphenous
vein reflux. In contrast to stripping that includes microphlebectomy, EVA is
generally performed in two stages (ablation followed, when needed, by
microphlebectomy or sclerotherapy). The purpose of this study was to
determine how often second stage procedures are required after EVA.
Methods: All consecutive patients undergoing laser EVA between
March 2007 andDecember 2008 were enrolled. At presentation, the clinical
severity of venous insufficiency was graded according to CEAP classification.
Patients were examined clinically/ultrasound at one week, and clinically at
one month. Varicose vein resolution following EVA was classified as excel-
lent (no varicosities), good (major reduction in size), and poor (no change).
Need for further intervention was determined at the one month follow-up.
Results: During the study period, 86 lower extremities in 76 patients
were treated with laser EVA (50 females, 26males, mean age 50 15 years).
By CEAP classification, 75 extremities were C2 (87.2%), five were C4
(5.8%), two were C5 (3.5%), and two were C6 (3.5%). Greater saphenous
veins were treated in 72 extremities (83.7%), small saphenous veins in 10
extremities (11.6%), anterior branch of the greater saphenous vein in two
extremities (2.3%), and both the greater saphenous vein and anterior branch
in two extremities (2.3%). The mean vein treatment length was 26.3  9.7
cm with a mean energy delivery of 64  11.3 Joules. At one week, all 86
extremities had the treated segment of vein closed and one of them had
partial extension of clot to the common femoral vein (1.16% incidence of
deep vein thrombosis [DVT]). At one month, complete resolution of
varicosities was found in 36 extremities (41.8%), reduction in size in 48
extremities (55.8%), and no improvement in two extremities (2.3%). Of the
patients with remaining varicosities, 15 extremities (17.4%) had small per-
sistent asymptomatic varicose veins of no concern to the patient. The
remaining 35 extremities (40.7%) required a second stage procedure.
Conclusions: After EVA, 59.3% of extremities did not require any
further treatment. These results justify the performance of EVA alone as a
first stage, as the majority of patients will be spared unnecessary microphle-
bectomy or sclerotherapy.
Evaluating the Availability of On-call Venous Duplex Scanning: ANew
Paradigm for Efficient Use of the Vascular Lab
Arnaoutakis G, Pirruccello J, Brooke B, Reifsnyder T
Objectives: Venous duplex ultrasound (VDU) is the standard evalua-
tion for acute deep vein thrombosis (DVT). Having the test available at all
hours imposes significant costs and universal availability may be unnecessary.
The purpose of this study was to compare the treatment and outcomes of
patients with suspectedDVT before (2005) and after (2007) eliminating the
availability of 24-hour VDU.
Methods: A retrospective cross-sectional study was performed among
patients evaluated by the emergency department (ED) for suspected DVT
during the years 2005 and 2007. The association of clinical variables, VDU
results, treatment, and complications were compared between time periods
using bivariate and multivariate regression models following propensity
score matching.
Results: In 2005 and 2007, 320 and 366 patients, respectively, had
VDU after referral by the ED. There were 31 acute DVTs in 2005 and 25 in
2007. There was no detected difference in thromboembolic complications.
Forty-nine (16%) tests during 2005 were done after hours. The number of
patients treated empirically before confirmation of DVT was significantly
higher in 2007: 51 (14%) vs 26 (8%) (P .019). Empiric treatment was also
more frequent in 2007 in patients confirmed to have acute DVT: seven
(28%) vs. three (7%) (P  .023). After matching patients by propensity
scores, regression models revealed a trend toward increased likelihood of
empiric treatment if patients had risk factor(s) known to indicate high risk for
DVT. There were no documented complications from empiric anti-coagu-
lation. Estimated savings for one year were $27,000.
Conclusions: The data suggest that elimination of around-the-clock
VDU services can render substantial savings to hospitals with no adverse
consequence in the acute management of DVT.
Long Term Functional Results of the Surgical Management of Neuro-
genic Thoracic Outlet Syndrome (NTOS)
Scali ST, Stone DH, Bjerke AA, Chang CK, Rzucidlo EM, Walsh DBObjectives: To document long-term functional outcomes in patients
treated for neurogenic thoracic outlet syndrome (NTOS).
